Geron (GERN) Interest Coverage Ratio (2010 - 2026)
Geron (GERN) posted Interest Coverage Ratio of 0.02 for Q1 2026, up 100.63% sequentially from 3.5 in Q4 2025, and up 101.09% YoY from 0.01 in Q1 2025.
Geron (GERN) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Geron has reported Interest Coverage Ratio for 17 years, with the latest figure at 0.02 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 101.09% year-over-year to 0.02 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.64 (up 71.64% YoY) and the FY2025 annual result came in at 0.15, up 61.83% from the prior year.
- Interest Coverage Ratio improved to 0.02 in Q1 2026 per GERN's latest filing, from 3.5 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.02 in Q1 2026 and troughed at 151.45 in Q4 2022.
- A 5-year average of 22.98 and a median of 17.7 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2026: Interest Coverage Ratio sank 403.88% in 2022, then soared 101.09% in 2026.
- Over 5 years, Interest Coverage Ratio stood at 151.45 in 2022, then surged by 65.06% to 52.91 in 2023, then soared by 95.65% to 2.3 in 2024, then slumped by 51.98% to 3.5 in 2025, then soared by 100.63% to 0.02 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.02, 3.5, and 1.61 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 1.42 |
| 10 | Geron | 1.04 Mn | -299.81 Mn | - | -1.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.75 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | -3.50 |
| Sep 30, 2025 | -1.61 |
| Jun 30, 2025 | -1.46 |
| Mar 31, 2025 | -2.04 |
| Dec 31, 2024 | -2.30 |
| Sep 30, 2024 | -9.26 |
| Jun 30, 2024 | -20.89 |
| Mar 31, 2024 | -16.35 |
| Dec 31, 2023 | -52.91 |
| Sep 30, 2023 | -23.05 |
| Jun 30, 2023 | -25.94 |
| Mar 31, 2023 | -20.86 |
| Dec 31, 2022 | -151.45 |
| Sep 30, 2022 | -21.99 |
| Jun 30, 2022 | -17.70 |
| Mar 31, 2022 | -19.39 |
| Dec 31, 2021 | -312.95 |
| Sep 30, 2021 | -24.27 |